FAST-1/2 Activators encompass a variety of chemical compounds that indirectly stimulate the transcriptional activity of FAST-1/2 through diverse cellular signaling pathways. Compounds such as Forskolin and Dibutyryl-cAMP elevate intracellular cAMP, leading to Protein Kinase A (PKA) activation which can phosphorylate and enhance FAST-1/2 activity. Similarly, IBMX works by inhibiting phosphodiesterases, thereby sustaining heightened cAMP levels and potentiating PKA's role in FAST-1/2 activation. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which has downstream effects that include the phosphorylation of transcription factors like FAST-1/2, while Lithium Chloride's inhibition of GSK-3 may result in the enhancement of signaling molecules that activate FAST-1/2. Furthermore, SB431542 can lead to an increase in FAST-1/2 activity by inhibiting TGF-β receptors, thus reducing competition for SMAD transcription factors that work alongside FAST-1/2.
The activity of FAST-1/2 is further influenced by Epigallocatechin Gallate (EGCG) and Sphingosine-1-Phosphate (S1P), where EGCG's kinase inhibition and S1P's receptor-mediated signaling can alleviate inhibitory pathways, indirectly promoting FAST-1/2 function. Proteasome inhibitor MG132 and anisomycin, a protein synthesis inhibitor, both contribute to the enhancement of FAST-1/2 by respectively preventing the degradation of signaling molecules and activating stress-activated protein kinases that can lead to FAST-1/2 activation. Okadaic Acid, acting as an inhibitor of protein phosphatases 1 and 2A, results in the augmented phosphorylation of proteins, including FAST-1/2, thereby potentially increasing its activity. Lastly, LY294002's inhibition of PI3K can adjust downstream signaling pathways, which may indirectly result in the enhancement of FAST-1/2 activity by affecting its phosphorylation dynamics. Collectively, these activators work through a network of signaling pathways that culminate in the amplification of FAST-1/2's transcriptional activity, demonstrating the multifaceted nature of cellular signaling in regulating protein function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, thereby increasing cAMP levels in cells. Elevated cAMP activates PKA, which can then phosphorylate transcription factors including FAST-1/2, leading to enhanced transcriptional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP, thus potentiating PKA activity and subsequent phosphorylation of FAST-1/2, enhancing its transcriptional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which can modulate the signaling pathways that phosphorylate substrates including FAST-1/2, thereby enhancing its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 can lead to the stabilization and activation of signaling molecules that increase the activity of transcription factors such as FAST-1/2. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β type I receptor ALK5, which can lead to the disinhibition of SMAD transcription factors that work synergistically with FAST-1/2 to enhance its function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates PKA, leading to the phosphorylation and enhancement of FAST-1/2 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) has been shown to inhibit certain types of kinases, potentially reducing competitive signaling pathways and indirectly enhancing the activity of FAST-1/2 through relief of inhibition. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate acts on its receptors to activate intracellular signaling cascades that can lead to the enhancement of transcription factors including FAST-1/2. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that can prevent the degradation of intracellular signaling molecules, thereby potentially increasing the signaling activity that leads to FAST-1/2 activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor which activates stress-activated protein kinases leading to the activation of transcription factors such as FAST-1/2. | ||||||